Chu Yu-Waye
Insider CIK 1854586 · FATE Senior VP Clinical Development · CTMX Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CTMX CytomX Therapeutics, Inc. | S Sale | 2026-03-17 | 2026-03-19 | 21,279 | $6.42 | $136.6K | 189,446 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2026-02-02 | 2026-02-04 | 300,000 | — | $0 | 300,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award | 2026-02-02 | 2026-02-04 | 75,000 | — | $0 | 210,725 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2025-09-26 | 2025-09-30 | 87,500 | — | $0 | 87,500 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2025-09-26 | 2025-09-30 | 43,750 | — | $0 | 43,750 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | S Sale | 2025-03-18 | 2025-03-20 | 4,025 | $0.60 | $2.4K | 135,725 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2025-02-04 | 2025-02-06 | 115,000 | — | $0 | 115,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2025-02-04 | 2025-02-06 | 238,000 | — | $0 | 238,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award | 2025-02-04 | 2025-02-06 | 56,000 | — | $0 | 82,250 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award | 2025-02-04 | 2025-02-06 | 57,500 | — | $0 | 139,750 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2024-01-18 | 2024-01-19 | 122,500 | — | $0 | 122,500 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2024-01-18 | 2024-01-19 | 75,000 | — | $0 | 75,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award | 2024-01-18 | 2024-01-19 | 26,250 | — | $0 | 26,250 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2023-07-19 | 2023-07-20 | 375,000 | — | $0 | 375,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | S Sale | 2023-04-18 | 2023-04-19 | 2,317 | $6.58 | $15.2K | 140,676 | SEC↗ |
| FATE FATE THERAPEUTICS INC | S Sale | 2023-04-18 | 2023-04-19 | 215 | $6.52 | $1.4K | 142,993 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2023-02-06 | 2023-02-07 | 425,000 | — | $0 | 425,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | S Sale | 2023-01-10 | 2023-01-11 | 7,825 | $5.24 | $41.0K | 143,208 | SEC↗ |
| FATE FATE THERAPEUTICS INC | S Sale | 2022-04-19 | 2022-04-21 | 4,062 | $35.37 | $143.7K | 151,033 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2022-01-25 | 2022-01-27 | 53,058 | — | $0 | 53,058 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award | 2022-01-25 | 2022-01-27 | 33,302 | — | $0 | 155,095 | SEC↗ |
| FATE FATE THERAPEUTICS INC | S Sale | 2022-01-11 | 2022-01-13 | 418 | $49.10 | $20.5K | 121,793 | SEC↗ |
| FATE FATE THERAPEUTICS INC | S Sale | 2022-01-11 | 2022-01-13 | 3,547 | $48.44 | $171.8K | 122,211 | SEC↗ |
| FATE FATE THERAPEUTICS INC | M Exercise deriv | 2021-12-10 | 2021-12-13 | 7,500 | — | $0 | 105,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | S Sale | 2021-12-10 | 2021-12-13 | 900 | $50.42 | $45.4K | 130,261 | SEC↗ |
| FATE FATE THERAPEUTICS INC | S Sale | 2021-12-10 | 2021-12-13 | 2,097 | $49.32 | $103.4K | 131,161 | SEC↗ |
| FATE FATE THERAPEUTICS INC | M Exercise | 2021-12-10 | 2021-12-13 | 7,500 | $16.32 | $122.4K | 133,258 | SEC↗ |
| FATE FATE THERAPEUTICS INC | S Sale | 2021-12-10 | 2021-12-13 | 1,822 | $52.37 | $95.4K | 127,394 | SEC↗ |
| FATE FATE THERAPEUTICS INC | S Sale | 2021-12-10 | 2021-12-13 | 1,031 | $53.66 | $55.3K | 126,363 | SEC↗ |
| FATE FATE THERAPEUTICS INC | S Sale | 2021-12-10 | 2021-12-13 | 5 | $55.54 | $278 | 125,758 | SEC↗ |
| FATE FATE THERAPEUTICS INC | S Sale | 2021-12-10 | 2021-12-13 | 600 | $54.58 | $32.7K | 126,763 | SEC↗ |
| FATE FATE THERAPEUTICS INC | S Sale | 2021-12-10 | 2021-12-13 | 1,045 | $51.08 | $53.4K | 129,216 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award | 2021-11-19 | 2021-11-22 | 60,958 | — | $0 | 125,758 | SEC↗ |
| FATE FATE THERAPEUTICS INC | S Sale | 2021-04-16 | 2021-04-20 | 1,500 | $84.41 | $126.6K | 64,800 | SEC↗ |
| FATE FATE THERAPEUTICS INC | S Sale | 2021-04-16 | 2021-04-20 | 875 | $81.80 | $71.6K | 67,200 | SEC↗ |
| FATE FATE THERAPEUTICS INC | S Sale | 2021-04-16 | 2021-04-20 | 900 | $82.91 | $74.6K | 66,300 | SEC↗ |